No Data
Pfizer in Pact With China's Fosun Pharma for Oral GLP-1 Drugs
Citi Initiates SHANGHAI FOSUN PHARMACEUTICAL GROUP(SFOSF.US) With Buy Rating, Announces Target Price $4.54
Henlius Biotech in Talks With J&J, Roche on Cancer Drug: Report
SHANGHAI FOSUN PHARMACEUTICAL GROUP To Go Ex-Dividend On July 24th, 2025 With 0.04493 USD Dividend Per Share
June 25th (Eastern Time) - $SHANGHAI FOSUN PHARMACEUTICAL GROUP(SFOSF.US)$ is trading ex-dividend on July 24th, 2025.Shareholders of record on July 25th, 2025 will receive 0.04493 USD dividend per
HSBC Initiates SHANGHAI FOSUN PHARMACEUTICAL GROUP(SFOSF.US) With Hold Rating, Announces Target Price $2.19
Shanghai Fosun Pharmaceutical Reports FY Results